MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on July 27, 2006; DOI: 10.1124/mol.106.029280


0026-895X/06/7004-1151-1154$20.00
Mol Pharmacol 70:1151-1154, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Related Article
Right arrow All Versions of this Article:
mol.106.029280v1
mol.106.029280v2
70/4/1151    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in MolPharm
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Remillard, C. V.
Right arrow Articles by Yuan, J. X.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Remillard, C. V.
Right arrow Articles by Yuan, J. X.-J.
Perspective

Transient Receptor Potential Channels and Caveolin-1: Good Friends in Tight Spaces

Carmelle V. Remillard, and Jason X.-J. Yuan

Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, California

Caveolae formation has raised the concept of energy efficiency to new heights. The ultimate purpose of caveolae formation is to colocalize signaling proteins with membrane microdomains in order to facilitate their interaction and improve signal transduction efficiency. Although we know that the main structural protein of caveolae is caveolin, how caveolin interacts with membrane proteins to facilitate their integration into lipid raft domains is unclear. A caveolin-scaffolding domain (CSD) on caveolin itself can associate with membrane proteins such as G proteins and endothelial nitric oxide synthase. In this issue, Kwiatek et al. (p. 1174) report that the TRPC1 channel protein contains a C-terminal CSD-consensus binding sequence that allows for its physical and functional interaction with caveolin-1 in the caveolae of human pulmonary artery endothelial cells (PAEC). Competitive interaction with a CSD-conjugated peptide attenuates thrombin- and thapsigargin-induced Ca2+ influx via store-operated TRPC1 channels. Their data suggest that caveolin-1 can directly regulate TRPC1 function, extending its already ascribed role as a structural protein.


Received July 25, 2006; accepted July 27, 2006

Address correspondence to: Jason X.-J. Yuan, Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0725. E-mail: xiyuan{at}ucsd.edu


Related articles in MolPharm:

Caveolin-1 Regulates Store-Operated Ca2+ Influx by Binding of Its Scaffolding Domain to Transient Receptor Potential Channel-1 in Endothelial Cells
Angela M. Kwiatek, Richard D. Minshall, David R. Cool, Randal A. Skidgel, Asrar B. Malik, and Chinnaswamy Tiruppathi
MolPharm 2006 70: 1174-1183. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
S. Langlois, K. N. Cowan, Q. Shao, B. J. Cowan, and D. W. Laird
Caveolin-1 and -2 Interact with Connexin43 and Regulate Gap Junctional Intercellular Communication in Keratinocytes
Mol. Biol. Cell, March 1, 2008; 19(3): 912 - 928.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
J. Tong, L. Nguyen, A. Vidal, S. A. Simon, J. H. P. Skene, and T. J. McIntosh
Role of GAP-43 in Sequestering Phosphatidylinositol 4,5-Bisphosphate to Raft Bilayers
Biophys. J., January 1, 2008; 94(1): 125 - 133.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics